Men's Health therapeutics Market Research Reports

"...... menopausal symptoms like hot flashes, osteoporosis, and low sexual desire in women, and to treat breast cancer in women. It is taken by mouth. In 2019, the market size of Methyltestosterone is xx million US$ and it will reach xx million US$ in......"

"...... ial for maintaining healthy muscle function) in individuals. The lack of dystrophin weakens muscle function, causes loss of ambulation, harms the respiratory and cardiac function, and ultimately leads to death. The main symptoms of this condit......"

"...... menopausal symptoms like hot flashes, osteoporosis, and low sexual desire in women, and to treat breast cancer in women. It is taken by mouth. The global Methyltestosterone market is valued at xx million US$ in 2018 and will reach xx million U......"

"...... ibuting to the rise in male infertility levels. The global Male Infertility market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study ar......"

"...... pment. Scope of the Report: Testosterone deficiency, also referred to as hypogonadism, is a common problem among men aged between 40 and 79 years, with some studies stating that nearly 30% of all men worldwide are affected by hy......"

"...... r /> Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence. The predisposing factors include tobacco usage, overweight, injuries, drug and alcohol u......"

"...... /> Male hypogonadism is a condition in which the body doesn't produce enough testosterone. Symptoms include fatigue, hot flashes, infertility, decrease in muscle mass and loss of bone mass (osteoporosis). Risk factors for hypogonadism include HIV/AID......"

"...... nd the United Kingdom) - Japan Study Period: 2016-2028 Male Hypogonadism Understanding and Treatment Algorithm The market report provides the overview of the Male Hypogonadism by providing the disease overv......"

"...... ts Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2028 Benign prostatic hyperplasia (BPH) Epidemiology The epidemiology sectio......"

"...... sales and also provides the Axiron sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In add......"